Feeds

Aussie smoko-proofing drug prevents ill effects of cigs

Well, most of them

Security for virtualized datacentres

Australian boffins have developed a treatment which allows mice to smoke cigarettes without the usual negative health consequences. The method could potentially allow gasper-loving humans to sidestep some of the self-destructive results of their habit.

The key to the business, according to lead cig-boffin Ross Vlahos, is Granulocyte macrophage-colony stimulating factor (GM-CSF), an agent released by the lungs when they are exposed to cigarette smoke. GM-CSF causes inflammatory leukocytes to activate in the lungs, which then leads to chronic obstructive pulmonary disease (COPD) and other complaints such as "oxidative stress, emphysema, small airway fibrosis, mucus hypersecretion and progressive airflow limitation".

Vlahos and his team at Melbourne uni decided to tackle this by the use of a blocking agent known as "anti GM-CSF". As called for by tradition, they got hold of a group of mice and dosed half of them with the miracle smoko-proofing drug, and left the others alone. Then all the mice were given "the equivalent of nine cigarettes of smoke each day for four days".

At the end of the test every single mouse was dead. However, this was simply because the boffins had killed them in order to examine their lungs. According to the mouse autopsies, the ones treated with "anti GM-CSF" were in much better nick than the others.

"Cigarette smoke-exposed mice that were treated with an anti-GM-CSF had significantly less lung inflammation in comparison to untreated mice," says Vlahos.

"This indicates that GM-CSF is a key mediator in smoke-induced lung inflammation and its neutralization may have therapeutic implications [for humans] in diseases such as COPD."

It would seem then that in future one may be able to take a shot or a pill and then happily puff away on one's little smoky treat, reassured in the knowledge that one's time in the 40-metre dash will be unaffected and the racking, sweaty, grey-faced smoker's cough will not make an appearance.

Unfortunately Anti GM-CSF isn't a cure-all, as the risk of cancer will still remain.

"Our treatment deals with cigarette smoke-induced lung inflammation involved in COPD, not cancer and other smoking-related ailments. Quitting remains the best and only cure for smoking-related lung disease," warns Vlahos sternly.

The smoko-proofing paper, Neutralizing GM-CSF Inhibits Cigarette Smoke-induced Lung Inflammation, is published online by the American Journal of Respiratory and Critical Care Medicine, here. ®

Internet Security Threat Report 2014

More from The Register

next story
SECRET U.S. 'SPACE WARPLANE' set to return from SPY MISSION
Robot minishuttle X-37B returns after almost 2 years in orbit
LOHAN crash lands on CNN
Overflies Die Welt en route to lively US news vid
'Utter killjoy Reg hacks have NEVER BEEN LAID', writes a fan
'Shuddit, smarty pants!' Some readers reacted badly to our last Doctor Who review ...
Experts brand LOHAN's squeaky-clean box
Phytosanitary treatment renders Vulture 2 crate fit for export
Carry On Cosmonaut: Willful Child is a poor taste Star Trek parody
Cringeworthy, crude and crass jokes abound in Steven Erikson’s sci-fi debut
White LED lies: It's great, but Nobel physics prize-winning great?
How artificial lighting could offer an artificial promise
NASA eyeballs SOLAR HEAT BOMBS, MINI-TORNADOES and NANOFLARES on Sun
Astro boffins probe fiery star's hidden depths
prev story

Whitepapers

Forging a new future with identity relationship management
Learn about ForgeRock's next generation IRM platform and how it is designed to empower CEOS's and enterprises to engage with consumers.
Win a year’s supply of chocolate
There is no techie angle to this competition so we're not going to pretend there is, but everyone loves chocolate so who cares.
Why cloud backup?
Combining the latest advancements in disk-based backup with secure, integrated, cloud technologies offer organizations fast and assured recovery of their critical enterprise data.
High Performance for All
While HPC is not new, it has traditionally been seen as a specialist area – is it now geared up to meet more mainstream requirements?
Saudi Petroleum chooses Tegile storage solution
A storage solution that addresses company growth and performance for business-critical applications of caseware archive and search along with other key operational systems.